Liver pathophysiology

COBALT Pediatrics

The issue

In 2021, we launched the COBALT study to find out if SARS-CoV-2 vaccines had a protective effect in chronic liver disease and after liver transplantation. Three centers, AAST Papa Giovanni XXIII Hospital (Italy), Hannover Medical School (Germany), and Hôpitaux Universitaires de Genève (Switzerland) run the study in a pediatric population.